Symrise stock: Q3 volume growth lifts sales as outlook holds

Symrise reported a stronger third quarter on October 28, 2026, with growth led by volumes across both operating segments. The company also retained its full-year targets, according to the Symrise Q3 2026 release.

At 16:14 Berlin time on October 29, Lang & Schwarz quoted the share at EUR 92.16. That was 2.63% above the verified Xetra close of EUR 89.80 from October 28, as reported by Finanznachrichten.de. This is a market comparison, not a claim about the reason for the share movement.

What has changed since the last report

The detailed earnings call added that third-quarter organic sales growth consisted of 6.1% volume growth and a negative pricing effect of 0.8%. Management said fourth-quarter organic growth should moderate because of tougher prior-year comparisons, while customer demand remains healthy. Full-year organic sales growth is expected near the midpoint of the 2% to 4% range, with adjusted EBITDA margin in the lower half of the 21.5% to 22.5% range.

Group sales reached EUR 1.31 billion, compared with EUR 1.22 billion in the prior-year quarter. Taste, Nutrition & Health generated organic growth of 5.2%, with reported sales of EUR 790 million, while Scent & Care grew organically by 5.6% and reported sales of EUR 520 million.

By the end of September, Symrise had repurchased 4.3 million shares under its buyback program. The program was scheduled to conclude on October 30, with the repurchased shares intended for cancellation. The company also said its Terpenes divestment and Floral Concept acquisition had been completed.

The new Lang & Schwarz quote was 4.56% below the EUR 96.56 level at 07:55 Berlin time cited in the previous October 28 pre-market report. The comparison is separate from the 2.63% intraday difference versus the October 28 Xetra close.

For broader market context, see current market reports.

See the latest news and analysis on Symrise stock.